AI-generated summary
This narrative review integrates molecular, neuropathological, animal, human, and clinical evidence on circadian disruption in Parkinson's disease. The authors report that circadian disruption may alter clock gene expression and melatonin secretion, and may contribute to sleep, autonomic, and mood symptoms. They describe light therapy, melatonin, and chronotherapy as possible approaches, while noting that the genetic causes remain incompletely understood.
- Who or what was studied
- patients with Parkinson's disease
- Limits stated in the abstract
- The abstract describes a narrative review, and the authors state that genetic causes are not fully elucidated and that underlying mechanisms may differ.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Bright light therapy, Depression. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.